QuantiFERON-TB Gold testing for tuberculosis in psoriasis patients commencing anti-tumour necrosis factor alpha therapy.
Desai
N
N
Raste
Y
Y
Cooke
N T
NT
Harland
C C
CC
D000328:Adult; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011565:Psoriasis / Q000188:drug therapy*; D011933:Reagent Kits, Diagnostic; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D014376:Tuberculosis / Q000175:diagnosis*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D011933:Reagent Kits, Diagnostic; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept